Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP852347.RAVU-Zozs8WR71ZaqM0RdyC0yd1Tt_2IoR9FuqokZPnOI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP852347.RAVU-Zozs8WR71ZaqM0RdyC0yd1Tt_2IoR9FuqokZPnOI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP852347.RAVU-Zozs8WR71ZaqM0RdyC0yd1Tt_2IoR9FuqokZPnOI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP852347.RAVU-Zozs8WR71ZaqM0RdyC0yd1Tt_2IoR9FuqokZPnOI130_provenance.
- NP852347.RAVU-Zozs8WR71ZaqM0RdyC0yd1Tt_2IoR9FuqokZPnOI130_assertion description "[Utilizing a large panel of human GCT tissue samples, we found that AMH type I receptors (ALK2, ALK3 and ALK6) and type II receptor (AMHRII), as well as their downstream effectors Smad1/5, are expressed and active in GCTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP852347.RAVU-Zozs8WR71ZaqM0RdyC0yd1Tt_2IoR9FuqokZPnOI130_provenance.
- NP852347.RAVU-Zozs8WR71ZaqM0RdyC0yd1Tt_2IoR9FuqokZPnOI130_assertion evidence source_evidence_literature NP852347.RAVU-Zozs8WR71ZaqM0RdyC0yd1Tt_2IoR9FuqokZPnOI130_provenance.
- NP852347.RAVU-Zozs8WR71ZaqM0RdyC0yd1Tt_2IoR9FuqokZPnOI130_assertion SIO_000772 21808236 NP852347.RAVU-Zozs8WR71ZaqM0RdyC0yd1Tt_2IoR9FuqokZPnOI130_provenance.
- NP852347.RAVU-Zozs8WR71ZaqM0RdyC0yd1Tt_2IoR9FuqokZPnOI130_assertion wasDerivedFrom befree-20140225 NP852347.RAVU-Zozs8WR71ZaqM0RdyC0yd1Tt_2IoR9FuqokZPnOI130_provenance.
- NP852347.RAVU-Zozs8WR71ZaqM0RdyC0yd1Tt_2IoR9FuqokZPnOI130_assertion wasGeneratedBy ECO_0000203 NP852347.RAVU-Zozs8WR71ZaqM0RdyC0yd1Tt_2IoR9FuqokZPnOI130_provenance.
- befree-20140225 importedOn "2014-02-25" NP852347.RAVU-Zozs8WR71ZaqM0RdyC0yd1Tt_2IoR9FuqokZPnOI130_provenance.